Markets have moved steadily higher in the past two weeks. The outcome of the US election, which had been a source of uncertainty that was keeping investors cautious, offered some stability. Sentiment got another big boost with the news that Phase 3 testing of two coronavirus vaccines showed effectiveness rates far higher than markets were expecting.

A number of aspects regarding these and other anti-corona products in development are still up in the air, such as how quickly they can be manufactured and what logistic problems the distribution process may bring, as well as medical questions such as effectiveness against re-infection.